Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,641,000
-39,000 (-2.32%)
At close: Dec 5, 2025

Samsung Biologics Market Cap

Samsung Biologics has a market cap or net worth of 75.96 trillion as of December 5, 2025. Its market cap has increased by 0.97% in one year.

Market Cap
75.96T
Enterprise Value
75.23T
Revenue
5.50T
Ranking
n/a
PE Ratio
47.60
Stock Price
1,641,000.00

Market Cap Chart

Since November 10, 2016, Samsung Biologics's market cap has increased from 9.53T to 75.96T, an increase of 697.29%. That is a compound annual growth rate of 25.71%.

History

DateMarket Cap% Change
Dec 5, 202575.96T12.46%
Dec 30, 202467.54T24.87%
Dec 28, 202354.09T-7.43%
Dec 29, 202258.43T-2.20%
Dec 30, 202159.75T9.32%
Dec 30, 202054.65T90.76%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Celltrion 40.11T
ALTEOGEN 24.41T
ABL Bio 10.51T
SK Biopharmaceuticals 10.49T
Yuhan 8,755.13B
LigaChem Biosciences 6,753.15B
Peptron 6,645.44B
HLB Co., Ltd. 6,460.44B
Market Cap Rankings